Open AccessSynergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro
Author(s) -
Pisin Chen
Publication year - 2006
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkl227
Subject(s) - mycobacterium tuberculosis , drug , in vitro , tuberculosis , ethylene diamine , diamine , first line , pharmacology , medicine , microbiology and biotechnology , chemistry , biology , biochemistry , pathology , organic chemistry , nuclear chemistry
The purpose of this study was to determine interactions of SQ109, a new asymmetric diamine tuberculosis (TB) drug candidate, with existing antitubercular drugs in vitro and assess its potential to improve combination drug activities against Mycobacterium tuberculosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom